2017HypertensionOpen access

Cardiovascular Risk Associated With White-Coat Hypertension

Giuseppe Mancia, Michele Bombelli, Cesare Cuspidi, Rita Facchetti, Guido M. Grassi

Open full text 52 citations

Abstract

T his article will support the view that white coat hyperten- sion (WCH), that is, the association of an elevated office with a normal ambulatory or home blood pressure (BP), 1 is not an innocent condition but a condition associated with an increased cardiovascular risk.This will be based on the evidence that compared with normotensive controls, subjects with WCH (1) have an increased prevalence of metabolic risk factors and asymptomatic organ damage; (2) more frequently progress to high cardiovascular risk states such as sustained hypertension, diabetes mellitus, and left ventricular hypertrophy; and(3) exhibit, over the mid and long term, a greater risk of cardiovascular morbid and fatal events.It will also be mentioned, however, that important clinical and mechanistic aspects of WCH remain incompletely clarified: the contribution of office versus out-of-office BP to the increased risk; the biomarkers that may allow to distinguish, within the WCH population, subjects at greater versus those at normal risk; and the effect of antihypertensive drug administration on patients' prognosis.Clarification of these aspects represents a priority for medical research because WCH is common in all hypertension grades, its prevalence accounting for more than one third of the hypertensive population when the office BP elevation is mild.

Open-access reader

About this research paper

What this paper is about

T his article will support the view that white coat hyperten- sion (WCH), that is, the association of an elevated office with a normal ambulatory or home blood pressure (BP), 1 is not an innocent condition but a condition associated with an increased cardiovascular risk.This will be based on the evidence that compared with normotensive controls, subjects with WCH (1) have an increased prevalence of metabolic risk factors and asymptomatic organ damage; (2) more frequently progress to high cardiovascular risk states such as sustained hypertension, diabetes mellitus, and left ventricular hypertrophy; and(3) exhibit, over the mid and long term, a greater risk of cardiovascular morbid and fatal events.It will also be mentioned, however, that important clinical and mechanistic aspects of WCH remain incompletely clarified: the contribution of office versus out-of-office BP to the increased risk; the biomarkers that may allow to distinguish, within the WCH population, subjects at greater versus those at normal risk; and the effect of antihypertensive drug administration on patients' prognosis.Clarification of these aspects represents a priority for medical research because WCH is common in all hypertension grades, its prevalence accounting for more than one third of the hypertensive population when the office BP elevation is mild.

Why it matters

OpenAlex reports 52 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

T his article will support the view that white coat hyperten- sion (WCH), that is, the association of an elevated office with a normal ambulatory or home blood pressure (BP), 1 is not an innocent condition but a condition associated with an increased cardiovascular risk.This will be based on the evidence that compared with normotensive controls, subjects with WCH (1) have an increased prevalence of metabolic risk factors and asymptomatic organ damage; (2) more frequently progress to high cardiovascular risk states such as sustained hypertension, diabetes mellitus, and left ventricular hypertrophy; and(3) exhibit, over the mid and long term, a greater risk of cardiovascular morbid and fatal events.It will also be mentioned, however, that important clinical and mechanistic aspects of WCH remain incompletely clarified: the contribution of office versus out-of-office BP to the increased risk; the biomarkers that may allow to distinguish, within the WCH population, subjects at greater versus those at normal risk; and the effect of antihypertensive drug administration on patients' prognosis.Clarification of these aspects represents a priority for medical research because WCH is common in all hypertension grades, its prevalence accounting for more than one third of the hypertensive population when the office BP elevation is mild.

Key concepts: Medicine

Related papers

Back to paper searchBrowse research topicsOriginal source
Cardiovascular Risk Associated With White-Coat Hypertension — Research Paper | ScholarLens